Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe record history now shows the study is no longer looking for participants. The latest revision tag has advanced to v3.6.0, replacing the previous v3.5.5 reference.SummaryDifference0.2%

- Check10 days agoChange DetectedA new page revision (v3.5.5) was added to the history, replacing the previous revision (v3.5.4). This reflects an updated version of the page for version tracking rather than substantive changes to study content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry, v3.5.4, was added to the history to replace the previous v3.5.3. This reflects an update to the page's revision record.SummaryDifference0.0%

- Check45 days agoChange DetectedThe record history now reflects a newer revision tag, updating from v3.5.2 to v3.5.3. This indicates an updated version of the study record history on the page.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the record history.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.